Global Mobile Gamma Camera Market Growth Analysis and Trends Report Application (Oncology, Cardiology, Neuroscience, Infection), By End Use (Hospitals, Diagnostic Centers, Research Institutions), By Technology (Anger System, Scintillation Camera, Single Photon Emission Computed Tomography), By Product Type (Cameras, Accessories, Software) and By Regions - Global Industry Forecast 2025 to 2035

Mobile Gamma Camera Market Overview

Mobile Gamma Camera Market Set for Strong Growth Through 2035

The Mobile Gamma Camera Market is witnessing rapid growth due to technological advancements, the rising prevalence of cancer, and increasing demand for portable imaging solutions. Valued at USD 1,192.2 million in 2024, the market is projected to reach USD 1,275.6 million in 2025 and is expected to expand to USD 2,500 million by 2035, registering a CAGR of 7.0%. B2B stakeholders, including medical device manufacturers, healthcare providers, and research institutions, are actively exploring innovative gamma imaging solutions to enhance diagnostic efficiency and patient outcomes.

Mobile gamma cameras are increasingly being adopted in hospitals, clinics, and diagnostic centers due to their portability, ease of use, and ability to deliver accurate nuclear imaging results. These devices play a crucial role in oncology, cardiology, and neurology applications, providing precise functional imaging that aids in early disease detection, treatment planning, and therapy monitoring.

Market Dynamics and Key Drivers

The growth of the Mobile Gamma Camera Market is driven by several key factors:

Technological Advancements: Enhanced imaging resolution, faster acquisition times, and AI-integrated software improving diagnostic accuracy.

Increasing Cancer Prevalence: Growing patient population requiring nuclear imaging for detection, staging, and therapy monitoring.

Demand for Portable Imaging Solutions: Hospitals and outpatient centers seeking flexible, point-of-care diagnostic devices.

Healthcare Expenditure Growth: Rising budgets in emerging and developed markets supporting adoption of advanced imaging equipment.

Aging Population: Increasing prevalence of chronic diseases among elderly patients driving demand for nuclear imaging solutions.

Manufacturers are investing in research and development to introduce compact, lightweight, and user-friendly gamma cameras. Integration with telemedicine platforms and cloud-based data management systems allows real-time image sharing, remote consultations, and improved patient care efficiency.

Regional Insights

North America dominates the Mobile Gamma Camera Market due to advanced healthcare infrastructure, high adoption of diagnostic technologies, and ongoing clinical research activities. The U.S. represents the largest market share, supported by investments in cancer research and nuclear medicine.

Europe holds a significant portion of the market with strong healthcare policies, high awareness of nuclear imaging benefits, and active collaborations between device manufacturers and research institutes. APAC is rapidly emerging as a lucrative market, especially in countries like China, India, Japan, and South Korea, due to increasing healthcare investments, expanding hospital networks, and rising awareness of early disease diagnosis. South America and MEA regions exhibit steady growth, driven by government initiatives and the gradual adoption of advance